Zelira Therapeutics Limited logo

Zelira Therapeutics Limited (ZLDAF)

Market Open
10 Aug, 20:00
OTCQB OTCQB
$
0. 26
-0.04
-13.3333%
$
4.16M Market Cap
- P/E Ratio
- Div Yield
2,500 Volume
- Eps
$ 0.3
Previous Close
Add Transaction
Day Range
0.26 0.3
Year Range
0.2 0.42
Want to track ZLDAF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

ZLDAF trading today lower at $0.26, a decrease of -13.3333% from yesterday's close, completing a monthly decrease of -25.7143% or -$0.09. Over the past 12 months, ZLDAF stock lost -4.2886%.
ZLDAF is not paying dividends to its shareholders.
The last earnings report, released on Feb 24, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Zelira Therapeutics Limited has completed 1 stock splits, with the recent split occurring on Apr 14, 2022.
The company's stock is traded on 4 different exchanges and in various currencies, with the primary listing on ASX (AUD).

ZLDAF Chart

People also search for

Security Devices International, Inc.
$ 1.01
-0.9804%
Vivos Inc.
$ 0.05
+5.8014%
Telescope Innovations Corp.
$ 0.31
+0.9536%
Inhibitor Therapeutics Inc.
$ 0.07
+27.1186%
Pacific Health Care Organization Inc.
$ 1
0%

Zelira Therapeutics Limited (ZLDAF) FAQ

What is the stock price today?

The current price is $0.26.

On which exchange is it traded?

Zelira Therapeutics Limited is listed on OTCQB.

What is its stock symbol?

The ticker symbol is ZLDAF.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 4.16M.

Has Zelira Therapeutics Limited ever had a stock split?

Zelira Therapeutics Limited had 1 splits and the recent split was on Apr 14, 2022.

Zelira Therapeutics Limited Profile

Biotechnology Industry
Healthcare Sector
- CEO
OTCQB Exchange
AU000000ZLD1 ISIN
Austria Country
- Employees
- Last Dividend
27 Jul 2016 Last Split
- IPO Date

Contact Information

Address: -
Phone: -